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Background: Dengue epidemic in Lahore (2011) resulted in hundreds of deaths and affected thousands. As most
of the studies were focused on its diagnosis and treatment, scanty data is available on associated diseases/
co-morbidities in these patients that could have contributed to a higher mortality. There were no local guidelines
available on recording, reporting and management of these co-morbidities. The objective of this study was to
analyze the initial presentations of dengue cases and to estimate the frequency of co-morbidities in dengue
patients.
Methods: Data of 556 dengue cases was retrieved from 2 major public sector tertiary-care hospitals for patients
who were admitted during 2011 epidemic and a case record analysis was done. Data was retrieved from patient’s
information reports which included demography, signs and symptoms and the laboratory investigations. In addition
verbal autopsy of deceased cases was also done from their relatives using standardized WHO verbal autopsy form
after making modifications as per needed.
Results: Of 556 cases studied, 390 (70%) were males. The mean age was 36 years and 30% of the cases were
between 20-29 years. Average duration of the hospital stay was 6 days. Out of the total, 435 (78%) were dengue
fever (DF) cases followed by dengue hemorrhagic fever (DHF) in 95 (17%) and dengue shock syndrome (DSS) in 26
(4%) cases. A total of 40 cases died and among them 17 were diagnosed with DSS, 13 DF and 10 DHF. Further the
verbal autopsy from relatives of deceased cases showed 29 (60%) deceased had co-morbid diseases which included
hypertension, diabetes etc. DSS was common in patients who had hypertension (27) either alone or associated with
other illnesses.
Conclusions: Co-morbidities with dengue infection were seen in 60% deceased cases indicating the reasons for
high dengue related complications and death.
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Dengue fever emerged from Africa almost 500-600 years
ago and reached Asia in 1780’s [1]. In recent decades, it
has become the second most prevalent mosquito (Aedes
aegypti) borne infection after malaria [2]. Dengue has
affected almost 120 countries with high incidence in
many [3] putting half of the world’s population at risk
[4]. According to WHO estimates, currently there are* Correspondence: arif289@gmail.com
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reproduction in any medium, provided the or50-100 million dengue cases around the world [5]. Den-
gue virus can lead to a spectrum of diseases ranging from
sub-clinical infection to dengue fever and most severe
forms like dengue hemorrhagic fever and dengue shock
syndrome [6].
Co-morbidities in dengue patients result in complica-
tions leading to deaths. A study from Singapore reported
that out of every 27 deaths due to dengue, 21 had co-
morbidities [7]. Another study reported that dengue pa-
tients with allergies or diabetes are 2.5 times more at risktd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Dengue serology of DF, DHF and DSS cases
Test DF (n 435) DHF (n 95) DSS (n 26)
IgG 48 22 2
IgM 85 40 4
IgG +M 302 33 20
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higher frequency of complications is reported in dengue
patients suffering from hepatitis [9-11].
Verbal autopsy is an indirect method of determining
cause of death based on interviews with the care takers of
deceased individuals and has been widely used to collect
information on cause specific mortality [12]. In addition to
gathering information on cause of death, verbal autopsy is
also important for investigating outbreaks due to infec-
tious diseases [13]. Many countries use verbal autopsy
methods on large scale to assess cause of death in a popu-
lation [14,15]. The present study was proposed to analyze
the initial symptoms of dengue fever and to determine the
frequency of co-morbidities in deceased cases.Table 2 Pattern of clinical presentation on day 1 of
dengue cases
Symptoms DF (n = 435) DHF (n = 95) DSS (n = 26)Methods
This was a retrospective, cross-sectional study and was
conducted in the community of Lahore and hospital re-
cords of two tertiary care hospitals i.e. King Edward
Medical University, Lahore (Mayo Hospital) and Fatima
Jinnah Medical College, Lahore (Ganga Ram Hospital).
Complete medical record of all dengue cases which in-
cluded signs and symptoms, method of diagnosis, manage-
ment, duration of stay and clinical outcome was retrieved
from patient’s information reports. The diagnosis of pa-
tients into DF, DHF and DSS was taken from their case
record and analyzed accordingly.
The relatives of deceased were interviewed using WHO
verbal autopsy guidelines (Additional file 1). Verbal
autopsy questionnaire were pre-tested by interviewing
attendants of fewer cases and modified as per needs.
All interviews were done by trained interviewers in local
language i.e. Urdu. A written informed consent was taken
from relative of deceased who were attendants of patient
during the hospital stay (father, brother, sister or others).
Demographic, epidemiological, co-morbidity and other
details were obtained from the relatives. A sample size
of 60 deceased was calculated for Lahore, however ver-
bal autopsy of 48 deceased cases was done (40 were
those whom addresses were retrieved from the records
of the selected 02 hospitals while 08 were included dur-
ing field interviews). These 08 cases were admitted in
any other hospitals of Lahore and died. The ethical
clearance was taken from Institutional ethic committee
of Pakistan Medical Research Council.Fever 435 (100%) 93 (97%) 26 (100%)
Bleeding 64 (15%) 56 (59%) **18 (72%)
Headache 326 (75%) 24 (25%) **24 (92%)
Vomit 323 (74%) 33 (35%) **25 (96%)
Abdominal pain 310 (71%) 35 (36%) **25 (96%)
Rash 127 (29%) 24 (25%) **15 (58%)
(**p < 0.05).Statistical analysis
Data collected was double entered in, cleared and coded
using Excel sheet (Window 2007) and analysis was done
using SPSS 16.0. Chi-square test was used to compare the
categorical variables and p ≤ 0.05 was considered statisti-
cally significant.Results
Of the total 556 cases, 390 (70%) were males and 166
(30%) females with a mean age of 36 years and majority
in 20-29 years age group. Average duration of hospital
stay was 6 days. The data showed that 435(78%) cases
had DF, 95 (17%) had DHF and 26 (4%) DSS. Majority
(64%) was positive for both IgG and IgM and pattern of
positivity in DF, DHF and DSS is given in Table 1. Five
day record of symptoms showed that all patients had a
high grade fever (103°F) at the time of admission which
settled or subsided by 5th day of admission. Fever, bleed-
ing, headache, vomiting, abdominal pain, rash and shock
were common symptoms on admission. However, bleed-
ing, vomiting, abdominal pain and rash were strongly
associated with DSS (Table 2).
Five days laboratory findings showed that HCT increased
at 3rd day in DF cases and then returned to normal however
this was constant in DHF (Figure 1). Thrombocytopenia
(platelets < 100,000) was observed in 515 (93%) however
29 (5%) cases suffered from severe thrombocytopenia
(platelets <10,000). ALT and AST were also de-ranged but
there was no significant difference between DF and DHF
(Figure 2). Records showed that platelets were transfused
in 260 patients (192 DF, 48 DHF and 20 DSS) in which 19
cases had severe thrombocytopenia while in 173 cases, the
count ranging from 11,000 to 40,000. About 68 (12%)
patients received platelets transfusion even their counts
was >40,000. The whole blood was given to 7 patients
(4 DF and 3 DHF). In the treatment chart, all patients
were treated in same fashion without any discrimin-
ation whether one had any other illness or not. The
case record analysis showed that about 40 cases died in
these hospitals. Among them 17 died of DSS, 13 from
DF, 10 from DHF.
Days
Figure 1 Pattern of Hematocrit (HCT) in DF and DHF cases. A rise in HCT was seen at 3rd week in DF patients which turned to normal.
However there was a consistent pattern of HCT in DHF patients. The data of DSS could not be compared as majority of them died and 05
records was not available.
Figure 2 Five days pattern of ALT (A) and AST (B) in DF and DHF cases. The level of liver enzyme (ALT and AST) was deranged in DF and
DHF cases. There was difference in level of ALT of DF cases from DHF at 3rd day of disease but this was not significant.
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The average age of deceased was 43 years and 22 were un-
married. Of the 48 diseased cases, 29 (60%) were suffering
from co-morbidities along with dengue infection. About
20 deceased patients had hypertension either alone or
along with any other illness and majority of them suffered
from DSS. Similarly diabetes and hepatitis B or C was also
another major risk of developing DSS.
The clinical signs and symptoms reported by deceased
attendants were: fever experienced by all patients followed
by chill and vigour in 36, headache and breathlessness
in 35, abdominal pain in 33, mental confusion in 35 and
unconsciousness in 34 cases. Similarly chest pain was
complained by 32 patients and this was sudden in onset
in 12 and gradual in 9 while 11 had severe chest pain.
Bleeding from nose, mouth and anus was reported
before death in 30 (63%) cases. Key warning signs were
severe and persistent vomiting and diarrhea about
4 days before death.
Discussion
The present study about verbal autopsy from relatives of
deceased dengue patients showed that 58% were suffering
from co-morbidities. Pakistan experienced a large dengue
epidemic in Lahore in 2011 resulting in thousands of
deaths. Unfortunately this was sudden and health depart-
ments were not well prepared and thus there was emphasis
on case management without following any local guide-
lines, especially for treating those with co-morbidities.
There was no systematic recording, reporting and manage-
ment of co-morbidities in dengue patients thus adding to
the mortality rate. Several studies have reported a strong
association of co-morbidities with increased complications
and deaths in dengue patients [7,16-18].
Male preponderance in present study was similar to
that reported in other studies [6,14,18,19]. Similarly,
fever, headache, bleeding, abdominal pain and rash were
common symptoms as seen previously [16,17]. Studies
also show a tendency towards higher age for the de-
ceased patients. Our study confirmed this as 62% were
more than 40 years [19,20] in comparison with two stud-
ies which report mean age less than 40 years [15,21]. In
about 12% cases, platelets were transfused while their
counts were >40,000. Irrational platelets transfusion in
dengue patients has been already reported from Pakistan
[22] as well as other countries [23,24].
The patients who had previous history of any illness are
more prone to develop complications. In the present
study, any deceased who had hypertension either alone or
along with any other illness and diabetes suffered from
DSS. A study from Taiwan reported that hypertension and
diabetes were risk factors for dengue hemorrhagic fever
and dengue shock syndrome [25]. The warning signs in
this study were severe and persistent vomiting anddiarrhea which are similar to previous reports [6] in the
deceased patients; fever followed by breathlessness, chills/
rigor, abdominal pain, headache, stiff neck, mental confu-
sion, unconsciousness and bleeding from mouth, nose and
anus were consistent to previous reports [17,6,26,27].
There were few potential limitations in the study. Firstly,
this was a retrospective analysis of available records, there-
fore many important information were incomplete. Sec-
ondly, data of verbal autopsies was based on the memory
of deceased attendants so they might have not recalled
properly.
Conclusions
In conclusion, majority of deaths in 2011 epidemics might
have been averted with better management of cases es-
pecially of those having co-morbidities.
Future strategies
This is recommended that efforts should be done to for-
mulate strategies for disease management especially for
screening the co-morbidities and capacity building of
physicians in both public and private sector hospitals to
cope with such epidemics in future and to avert deaths.
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